{"mainPropery":{"diseaseId":12375,"diseaseName":"Idiopathic CD4 positive T-lymphocytopenia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12375/idiopathic-cd4-positive-t-lymphocytopenia","synonyms":["IMMUNODEFICIENCY 13","IMD13","ICL","IDIOPATHIC CD4 LYMPHOPENIA","Idiopathic CD4 lymphocytopenia"],"synonyms-with-source":[{"name":"IMMUNODEFICIENCY 13","source":"OMIM"},{"name":"IMD13","source":"OMIM"},{"name":"ICL","source":"OMIM"},{"name":"IDIOPATHIC CD4 LYMPHOPENIA","source":"OMIM"},{"name":"Idiopathic CD4 lymphocytopenia","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"615518"},{"identifierType":"ORPHANET","identifierId":"228000"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/615518' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://clinicaltrials.gov/ct2/results?term=Idiopathic+CD4+positive+T-lymphocytopenia&recr=Open&no_unk=Y&type=&rslt=&age_v=&gndr=&cond=&intr=&titles=&outc=&spons=&lead=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&rcv_s=&rcv_e=&lup_s=&lup_e=' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Idiopathic CD4 positive T-lymphocytopenia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=228000' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:615518' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":10996,"questionText":"What is idiopathic CD4 positive T-lymphocytopenia?","answerText":"<strong>Idiopathic CD4 positive T-lymphocytopenia (ICL)&nbsp;</strong>is a rare disorder of the <a href=\"https://medlineplus.gov/immunesystemanddisorders.html\" target=\"_blank\">immune system</a>. People with ICL have&nbsp;low levels of a type of white blood cell, called a CD4+ <a href=\"https://askabiologist.asu.edu/t-cell\" target=\"_blank\">T cell</a>. These low levels can <span style=\"text-decoration: underline;\">not</span> be explained by other causes of immunodeficiency, including&nbsp;<a href=\"https://medlineplus.gov/hivaids.html\" target=\"_blank\">HIV infection</a>.[12089] T cells have many jobs in our immune system, such as attacking bacteria and viruses.[12090] CD4 is a protein found on the surface of many different cells within your immune system. It lets the different cells of your immune system work with each other. When CD4+ T cells are decreased, your body becomes more prone to infection.[12089]<br />\r\n<br />\r\nSigns and Symptoms of ICL vary. Some people have no symptoms, however most have illnesses suggestive of a lowered immune system, including infections (<a href=\"https://vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta?v%3Aproject=medlineplus&amp;query=varicella\" target=\"_blank\">varicella-zoster virus</a>, <a href=\"http://www.cancer.org/cancer/cancercauses/othercarcinogens/infectiousagents/hpv/hpv-and-hpv-testing\" target=\"_blank\">human papilloma virus</a>), autoimmune disorders (<a href=\"https://rarediseases.info.nih.gov/diseases/5870/autoimmune-hemolytic-anemia\" target=\"_blank\">autoimmune hemolytic anemia</a>, <a href=\"https://rarediseases.info.nih.gov/diseases/10253/lupus\" target=\"_blank\">lupus</a>), and certain types of cancer (<a href=\"https://medlineplus.gov/lymphoma.html\" target=\"_blank\">non-Hodgkin lymphoma</a>).[12089] A few people with ICL are found to carry specific  <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>  <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>;&nbsp;however, for most cases of ICL the underlying cause is not known.[12089][12091] Currently, there is no cure for ICL, but treatments are available to help manage individual symptoms.[12089]","dateModified":"2016-08-25T00:00:00"},"basicQuestions":[{"questionId":11000,"questionText":"What are the signs and symptoms of idiopathic CD4 positive T-lymphocytopenia (ICL)?","answerText":"The signs and symptoms of ICL usually become apparent in adulthood; although the age at time of diagnosis ranges from 1 year of age to 58 years of age. While some individuals may be asymptomatic, most come to medical attention after diagnosis of an infection related to a weakened immune system, called an <a href=\"https://www.aids.gov/hiv-aids-basics/staying-healthy-with-hiv-aids/potential-related-health-problems/opportunistic-infections/\" target=\"_blank\">opportunistic infection</a>.[12098][12099] These infections are similar to illnesses found in individuals with <a href=\"https://medlineplus.gov/hivaids.html\" target=\"_blank\">AIDS</a> and may include:[12098][12099]<br />\r\n<ul>\r\n    <li>Bacterial:<em>&nbsp;<a href=\"https://medlineplus.gov/mycobacterialinfections.html\" target=\"_blank\"></a></em><a href=\"https://medlineplus.gov/mycobacterialinfections.html\" target=\"_blank\">Mycobacterium</a>, <a href=\"https://medlineplus.gov/salmonellainfections.html\" target=\"_blank\">Salmonella</a>, <a href=\"https://medlineplus.gov/ency/article/000679.htm\" target=\"_blank\">Nocardia</a></li>\r\n    <li>Fungal:<em>&nbsp;<a href=\"http://www.cdc.gov/fungal/diseases/candidiasis/\" target=\"_blank\"></a></em><a href=\"http://www.cdc.gov/fungal/diseases/candidiasis/\" target=\"_blank\">Candidiasis</a>,&nbsp;<a href=\"https://medlineplus.gov/ency/article/001328.htm\" target=\"_blank\">Cryptococcus</a>,&nbsp;<a href=\"https://medlineplus.gov/histoplasmosis.html\" target=\"_blank\">Histoplasmosis</a></li>\r\n    <li>Viral: <a href=\"https://medlineplus.gov/cytomegalovirusinfections.html\" target=\"_blank\">Cytomegalovirus</a>, <a href=\"https://vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta?v%3Aproject=medlineplus&amp;v%3Asources=medlineplus-bundle&amp;query=varicella+\" target=\"_blank\">varicella zoster virus</a>, <a href=\"https://medlineplus.gov/hpv.html\" target=\"_blank\">human papillomaviruses</a></li>\r\n    <li>Parasitic:&nbsp;<a href=\"https://medlineplus.gov/toxoplasmosis.html\" target=\"_blank\">Toxoplasmosis</a>,&nbsp;<a href=\"https://medlineplus.gov/leishmaniasis.html\" target=\"_blank\">leishmaniasis</a></li>\r\n</ul>\r\nAutoimmune disorders including <a href=\"https://rarediseases.info.nih.gov/diseases/10252/sjogren-syndrome\" target=\"_blank\">Sj&ouml;gren syndrome</a>, <a href=\"https://rarediseases.info.nih.gov/diseases/7607/sarcoidosis\" target=\"_blank\">sarcoidosis</a>, <a href=\"https://rarediseases.info.nih.gov/diseases/10262/psoriasis\" target=\"_blank\">psoriasis</a>, <a href=\"https://rarediseases.info.nih.gov/diseases/5870/autoimmune-hemolytic-anemia\" target=\"_blank\">autoimmune hemolytic anemia</a>, and <a href=\"https://rarediseases.info.nih.gov/diseases/10253/lupus\" target=\"_blank\">lupus</a> and malignancies (cancers) including <a href=\"https://rarediseases.info.nih.gov/diseases/1091/squamous-cell-carcinoma\" target=\"_blank\">squamous cell carcinoma</a>, and&nbsp;<a href=\"https://medlineplus.gov/lymphoma.html\" target=\"_blank\">lymphoma</a> may also occur.[12098]","dateModified":"2016-08-25T10:26:00","resourceClassificationName":"Symptoms","references":[{"referenceId":12098,"authors":"Dina S. Ahmad, Mohammad Esmadi, William C. Steinmann","articleTitle":"Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases","bookWebsiteJournalTitle":"Avicenna J Med","date":"April-June 2013","volume":"3(2)","pages":"37-47","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734630/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12099,"authors":"Luo L, Li T","articleTitle":"Idiopathic CD4 lymphocytopenia and opportunistic infection--an update","bookWebsiteJournalTitle":"FEMS Immunol Med Microbiol","date":"Dec 2008","volume":"54(3)","pages":"283-289","url":"http://femsim.oxfordjournals.org/content/54/3/283.long","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11001,"questionText":"What causes idiopathic CD4 positive T-lymphocytopenia (ICL)?","answerText":"The cause of ICL is not well understood. Contributing factors may be related to CD4+ <a href=\"https://askabiologist.asu.edu/t-cell\" target=\"_blank\">T cell</a> development and function, various deficiencies of the <a href=\"https://medlineplus.gov/immunesystemanddisorders.html\" target=\"_blank\">immune system</a>, and genetic factors.[12098][12100]","dateModified":"2016-08-25T11:05:00","resourceClassificationName":"Cause","references":[{"referenceId":12098,"authors":"Dina S. Ahmad, Mohammad Esmadi, William C. Steinmann","articleTitle":"Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases","bookWebsiteJournalTitle":"Avicenna J Med","date":"April-June 2013","volume":"3(2)","pages":"37-47","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734630/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12100,"authors":"Gholamin, Mehrana; Bazi, Alib; Abbaszadegan, Mohammad Rezac","articleTitle":"Idiopathic lymphocytopenia","bookWebsiteJournalTitle":"Current Opinion in Hematology","date":"January 2015","volume":"22(1)","pages":"46-52","url":"http://www.ncbi.nlm.nih.gov/pubmed/25463685","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11002,"questionText":"How is idiopathic CD4 positive T-lymphocytopenia (ICL) diagnosed?<br />","answerText":"There are no universal diagnostic criteria for ICL; however, it should be suspected in an individual with laboratory findings including CD4+ T cell counts below 300 cells/mm3 or less than 20 percent of total lymphocytes in the absence of other immunodeficiencies, including <a href=\"https://medlineplus.gov/hivaids.html\" target=\"_blank\">HIV</a>.[12089]<br />\r\n<br />\r\nThe following diseases may also cause decreased CD4+ T cell counts and could be considered as an alternative diagnosis: acute or chronic retroviral infections (HIV,&nbsp;<a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=269420\" target=\"_blank\">human T-lymphotropic virus type 1</a>), <a href=\"https://rarediseases.info.nih.gov/diseases/7607/sarcoidosis\" target=\"_blank\">sarcoidosis</a>, <a href=\"https://rarediseases.info.nih.gov/diseases/6140/common-variable-immunodeficiency\" target=\"_blank\">common variable immunodeficiency</a>, congenital immunodeficiencies, and immunosuppressive states induced by <a href=\"https://medlineplus.gov/cancerchemotherapy.html\" target=\"_blank\">chemotherapy</a>, <a href=\"https://medlineplus.gov/ency/article/000103.htm\" target=\"_blank\">acute respiratory distress syndrome</a>, or <a href=\"https://medlineplus.gov/autoimmunediseases.html\" target=\"_blank\">autoimmune disorders</a>.[12089]","dateModified":"2016-08-25T12:47:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":12089,"authors":"Karin Nielsen-Saines","articleTitle":"Idiopathic CD4+ lymphocytopenia","bookWebsiteJournalTitle":"UpToDate","date":"July 31, 2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/idiopathic-cd4-lymphocytopenia?source=search_result&search=Idiopathic+CD4%2B+lymphocytopenia&selectedTitle=1~19","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11003,"questionText":"How might idiopathic CD4 positive T-lymphocytopenia (ICL) be treated?","answerText":"Treatment of ICL mainly focuses on managing associated symptoms. For individuals without symptoms, regular measurement of CD4+ T cell counts and antibiotic use may be suggested. There are no guidelines regarding how frequently monitoring should occur.[12089]<br />\r\n<br />\r\nTwo different methods to increase CD4+ T cell counts have been used on a few affected individuals with varying levels of success: <a href=\"http://www.oncolink.org/cancer-treatment/chemotherapy/oncolink-rx/interleukin-2-proleukin-r-il-2-aldesleukin\" target=\"_blank\">Interleukin-2 (IL2)</a> and <a href=\"https://medlineplus.gov/ency/article/003009.htm\" target=\"_blank\">bone marrow transplantation</a>.[12089][12100] IL2 is a type of protein naturally occurring in the immune system that works to increase the production and function of the immune system.[12101]&nbsp;A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow (soft, fatty tissue inside your bones that produces blood cells) with healthy bone marrow stem cells.&nbsp;Stem cells are immature cells in the bone marrow that give rise to all of your different blood cells.[12102]","dateModified":"2016-08-25T13:13:00","resourceClassificationName":"Treatment","references":[{"referenceId":12089,"authors":"Karin Nielsen-Saines","articleTitle":"Idiopathic CD4+ lymphocytopenia","bookWebsiteJournalTitle":"UpToDate","date":"July 31, 2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/idiopathic-cd4-lymphocytopenia?source=search_result&search=Idiopathic+CD4%2B+lymphocytopenia&selectedTitle=1~19","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12100,"authors":"Gholamin, Mehrana; Bazi, Alib; Abbaszadegan, Mohammad Rezac","articleTitle":"Idiopathic lymphocytopenia","bookWebsiteJournalTitle":"Current Opinion in Hematology","date":"January 2015","volume":"22(1)","pages":"46-52","url":"http://www.ncbi.nlm.nih.gov/pubmed/25463685","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12101,"authors":"OncoLink Team","articleTitle":"Interleukin-2 (Proleukin®, IL-2, Aldesleukin)","bookWebsiteJournalTitle":"OncoLink","date":"January 4, 2016","volume":"","pages":"","url":"http://www.oncolink.org/cancer-treatment/chemotherapy/oncolink-rx/interleukin-2-proleukin-r-il-2-aldesleukin","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12102,"authors":"","articleTitle":"Bone marrow transplant","bookWebsiteJournalTitle":"MedlinePlus","date":"2/12/2016","volume":"","pages":"","url":"https://medlineplus.gov/ency/article/003009.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11004,"questionText":"What is the long-term outlook for idiopathic CD4 positive T-lymphocytopenia (ICL)?","answerText":"The long-term outlook (prognosis) for individuals with ICL varies depending on the extent of immunosuppression and the  associated symptoms. Rarely, ICL can be a temporary finding that reverses over time. In most cases the level of CD4+ T cells stabilizes, rather than continuing to decrease.[12089]","dateModified":"2016-08-25T13:33:00","resourceClassificationName":"Prognosis","references":[{"referenceId":12089,"authors":"Karin Nielsen-Saines","articleTitle":"Idiopathic CD4+ lymphocytopenia","bookWebsiteJournalTitle":"UpToDate","date":"July 31, 2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/idiopathic-cd4-lymphocytopenia?source=search_result&search=Idiopathic+CD4%2B+lymphocytopenia&selectedTitle=1~19","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":8354,"authors":"Walker UA & Warnatz K","articleTitle":"Idiopathic CD4 lymphocytopenia","bookWebsiteJournalTitle":"Curr Opin Rheumatol","date":"July, 2006","volume":"18(4)","pages":"389-95.","url":"http://www.ncbi.nlm.nih.gov/pubmed/16763460","dateAccessed":"2015-02-19T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8355,"authors":"Gholamin M, Bazi A & Abbaszadegan MR","articleTitle":"Idiopathic lymphocytopenia","bookWebsiteJournalTitle":"Curr Opin Hematol","date":"January, 2015","volume":"22(1)","pages":"46-52","url":"http://www.ncbi.nlm.nih.gov/pubmed/25463685","dateAccessed":"2015-02-19T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8356,"authors":"Said S & cols","articleTitle":"Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review","bookWebsiteJournalTitle":"Int Med Case Rep J","date":"July 30, 2014","volume":"7","pages":"117-20","url":"http://www.ncbi.nlm.nih.gov/pubmed/25114596","dateAccessed":"2015-02-19T00:00:00","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":13215,"phenoTypeName":"Bronchiolitis obliterans organizing pneumonia","percentRanges":"-"},{"phenoTypeId":10673,"phenoTypeName":"Immunodeficiency","percentRanges":"-"},{"phenoTypeId":15526,"phenoTypeName":"Lymphopenia","percentRanges":"-"},{"phenoTypeId":13723,"phenoTypeName":"Pneumonia","percentRanges":"-"},{"phenoTypeId":11334,"phenoTypeName":"Recurrent otitis media","percentRanges":"-"},{"phenoTypeId":8814,"phenoTypeName":"Recurrent shingles","percentRanges":"-"},{"phenoTypeId":318,"phenoTypeName":"Recurrent sinusitis","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Idiopathic_CD4_positive_T-lymphocytopenia"}